In contrast, parathyroid hormone (PTH), which is a bone anabolic agent, has had clinical applications in the treatment of osteoporosis, and it has been reported to have significant effects in increasing bone mineral density (BMD) and inhibiting fractures [13]; recently, similar effects were obtained even with intermittent administration given once a week [14]. Here, PTH is linked to osteoporosis.